Response and remission criteria for clinical trials in lupus-what can we learn from other diseases?
Schneider
M
M
Department of Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany. schneider@rheumanet.org
D018849:Controlled Clinical Trials as Topic / Q000379:methods*; D018572:Disease-Free Survival; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome